Armstrong Advisory Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82 | Hold |
120
| – | – | ﹤0.01% | 918 |
|
|
2025
Q1 | $131 | Hold |
120
| – | – | ﹤0.01% | 833 |
|
|
2024
Q4 | $131 | Hold |
120
| – | – | ﹤0.01% | 833 |
|
|
2024
Q3 | $91 | Hold |
120
| – | – | ﹤0.01% | 778 |
|
|
2024
Q2 | $149 | Hold |
120
| – | – | ﹤0.01% | 785 |
|
|
2024
Q1 | $317 | Hold |
120
| – | – | ﹤0.01% | 757 |
|
|
2023
Q4 | $317 | Hold |
120
| – | – | ﹤0.01% | 757 |
|
|
2023
Q3 | $276 | Hold |
120
| – | – | ﹤0.01% | 824 |
|
|
2023
Q2 | $438 | Hold |
120
| – | – | ﹤0.01% | 782 |
|
|
2023
Q1 | $429 | Hold |
120
| – | – | ﹤0.01% | 763 |
|
|
2022
Q4 | $342 | Buy |
+120
| New | +$342 | ﹤0.01% | 791 |
|